[1]国家卫生健康委办公厅,国家中医药管理局办公室.新型冠状病毒感染的肺炎诊疗方案(试行第五版):国卫办医函〔2020〕103号[EB/OL].(2020-02-05)[2020-02-06].http://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474791.htm. [2]中华人民共和国国家卫生健康委员会,疾病预防控制局.中华人民共和国国家卫生健康委员会公告:2020年第1号[EB/OL].(2020-01-20)[2020-02-15]. [3]李六亿,吴安华.新型冠状病毒医院感染防控常见困惑探讨[J].中国感染控制杂志,2020,19(2):105-108.DOI:10.12138/j.issn.1671-9638.20205362. [4]WHO. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020[EB/OL].[2020-02-15]. https://www.who.int/dg/speeches/detail/whodirector-general-s-remarks-at-the-media-briefing-on-2019- ncov-on-11-february-2020. [5]新型冠状病毒肺炎诊疗方案(试行第六版)[J]. 中国感染控制杂志,2020,02:192-195. [6]Masters PS. Coronavirus genomic RNA packaging[J]. Virology, 2019, 537: 198-207. [7]徐超,刘容枝,方丽,李冉,韩从音,吕允凤.新型冠状病毒2019-nCoV核酸检测试剂临床试验要求解析[J]. 中国医药生物技术,2020,03:225-229. [8]国家卫生健康委员会办公厅. 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL]. (2020-03-03)[2020-03-05]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml. [9]Huang CL, Wang YM, Li XW, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. [10]上海市医学会检验医学分会.新型冠状病毒核酸和抗体检测临床应用专家共识[J].国际检验医学杂志,2020,41(14):1665-1669. [11]中华人民共和国卫生部.医疗机构消毒技术规范:WS/T 367-2012[S].北京,2012. [12]WHO/CDS/CSR/EPH. Prevention of hospital-acquired infections; a practical guide[S]. WHO, 2002. [13]Ling ML, Ching P, Widitaputra A, et al. APSIC guidelines for disinfection and sterilization of instruments in health care facilities[J]. Antimicrob Resist Infect Control, 2018, 7: 25. |